Check out your Company Bowl for anonymous work chats.
Huma Appoints Kaushik Gune as Head of U.S. Healthcare Business to Promote Adoption of Digital Health Solutions Kaushik Gune joins Huma to drive further commercial adoption of the company’s digital health platforms in the U.S., specifically its ‘Care at Home’ platform for remote patient monitoring.
Remote patient monitoring pilot shortlisted for two prestigious HSJ Awards The project has been nominated in the ‘Digitising Patient Care’ category at the HSJ Awards and ‘Virtual or Remote Care Initiative of the Year’ category at the HSJ Patient Safety Awards.
We are truly humbled to be Europe's fastest-growing healthcare company and listed number 23 across all industries. Thank you for the belief in us to help people live longer, fuller lives. Read more here in the Financial Times: https://lnkd.in/dVQFRYU
Huma has been recognised by Switch as one of the top 10 startups helping to fight COVID-19 in the UK. The Singapore Week of Innovation and TeCHnology (SWITCH) noted our collaboration with global partners, such as Johns Hopkins, in validating digital biomarkers to identify individual risk for COVID-19, and to monitor respiratory symptoms and progression.
There is a significant disconnect between employers and employees on how businesses should get back up and running during COVID?19. How can we close this disconnect? Download our free research report, analysing attitudes from 10,000 workers and 4,000 employers in the UK and USA.
Huma is proud to power one of the world?s largest and most extensive COVID-19 clinical studies. The University of Cambridge?s Fenland Study, which is working on the early detection of COVID-19 infections, uses Huma?s platform, remote patient monitoring technology, and digital biomarkers to potentially save lives and limit the spread of the disease. Find out more on University of Cambridge's website ?? https://lnkd.in/g5uVTEp #COVID19 #coronavirus #cambridgeuniversity #healthtech #digitalhealth #healthcare
Dan Vahdat, our CEO & Founder, spoke at the Amazon Web Services (AWS) Healthcare & Life Sciences Web Day about how technology can help build resilient healthcare systems during COVID-19 and beyond. Listen on-demand on Amazon ➡️ https://lnkd.in/g29TZrC
Dan Vahdat, our Founder & CEO, met with Dr. Thomas Solbach of Strategy&, part of PwC, to discuss the possibilities digital biomarkers have for modern medicine. Together, they go into the future of diagnosing diseases in the earliest stages, leading to more preventative and personalised care. Listen to the podcast below ⬇️
Our research on the telemonitoring of patients with heart failure was amongst the top 10% most downloaded papers in the ESC Heart Failure journal. Read the paper for free on the link below.
In addition to our new brand, we have acquired BioBeats and Tarilian Laser Technologies (TLT). These acquisitions allow us to build on our product offerings – adding mental health and cardiovascular capabilities – and accelerate our work in digital biomarkers and therapeutics.
